Ubiquitin is phosphorylated by PINK1 to activate parkin
- PMID: 24784582
- DOI: 10.1038/nature13392
Ubiquitin is phosphorylated by PINK1 to activate parkin
Abstract
PINK1 (PTEN induced putative kinase 1) and PARKIN (also known as PARK2) have been identified as the causal genes responsible for hereditary recessive early-onset Parkinsonism. PINK1 is a Ser/Thr kinase that specifically accumulates on depolarized mitochondria, whereas parkin is an E3 ubiquitin ligase that catalyses ubiquitin transfer to mitochondrial substrates. PINK1 acts as an upstream factor for parkin and is essential both for the activation of latent E3 parkin activity and for recruiting parkin onto depolarized mitochondria. Recently, mechanistic insights into mitochondrial quality control mediated by PINK1 and parkin have been revealed, and PINK1-dependent phosphorylation of parkin has been reported. However, the requirement of PINK1 for parkin activation was not bypassed by phosphomimetic parkin mutation, and how PINK1 accelerates the E3 activity of parkin on damaged mitochondria is still obscure. Here we report that ubiquitin is the genuine substrate of PINK1. PINK1 phosphorylated ubiquitin at Ser 65 both in vitro and in cells, and a Ser 65 phosphopeptide derived from endogenous ubiquitin was only detected in cells in the presence of PINK1 and following a decrease in mitochondrial membrane potential. Unexpectedly, phosphomimetic ubiquitin bypassed PINK1-dependent activation of a phosphomimetic parkin mutant in cells. Furthermore, phosphomimetic ubiquitin accelerates discharge of the thioester conjugate formed by UBCH7 (also known as UBE2L3) and ubiquitin (UBCH7∼ubiquitin) in the presence of parkin in vitro, indicating that it acts allosterically. The phosphorylation-dependent interaction between ubiquitin and parkin suggests that phosphorylated ubiquitin unlocks autoinhibition of the catalytic cysteine. Our results show that PINK1-dependent phosphorylation of both parkin and ubiquitin is sufficient for full activation of parkin E3 activity. These findings demonstrate that phosphorylated ubiquitin is a parkin activator.
Comment in
-
Neurological disorders: Quality-control pathway unlocked.Nature. 2014 Jun 5;510(7503):44-5. doi: 10.1038/510044a. Nature. 2014. PMID: 24899302 No abstract available.
Similar articles
-
Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL.J Biol Chem. 2019 Jun 28;294(26):10300-10314. doi: 10.1074/jbc.RA118.006302. Epub 2019 May 20. J Biol Chem. 2019. PMID: 31110043 Free PMC article.
-
Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation.EMBO Rep. 2015 Aug;16(8):939-54. doi: 10.15252/embr.201540352. Epub 2015 Jun 25. EMBO Rep. 2015. PMID: 26116755 Free PMC article.
-
Molecular mechanisms underlying PINK1 and Parkin catalyzed ubiquitylation of substrates on damaged mitochondria.Biochim Biophys Acta. 2015 Oct;1853(10 Pt B):2791-6. doi: 10.1016/j.bbamcr.2015.02.009. Epub 2015 Feb 18. Biochim Biophys Acta. 2015. PMID: 25700839 Review.
-
PINK1/Parkin-mediated mitophagy in mammalian cells.Curr Opin Cell Biol. 2015 Apr;33:95-101. doi: 10.1016/j.ceb.2015.01.002. Epub 2015 Feb 17. Curr Opin Cell Biol. 2015. PMID: 25697963 Review.
-
Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.J Biol Chem. 2013 Jul 26;288(30):22019-32. doi: 10.1074/jbc.M113.467530. Epub 2013 Jun 10. J Biol Chem. 2013. PMID: 23754282 Free PMC article.
Cited by
-
Chinese botanical drugs targeting mitophagy to alleviate diabetic kidney disease, a comprehensive review.Front Pharmacol. 2024 May 13;15:1360179. doi: 10.3389/fphar.2024.1360179. eCollection 2024. Front Pharmacol. 2024. PMID: 38803440 Free PMC article. Review.
-
KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy.Sci Rep. 2024 May 22;14(1):11721. doi: 10.1038/s41598-024-60602-9. Sci Rep. 2024. PMID: 38777823 Free PMC article.
-
PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants.Cell Mol Life Sci. 2024 May 20;81(1):223. doi: 10.1007/s00018-024-05262-8. Cell Mol Life Sci. 2024. PMID: 38767677 Free PMC article. Review.
-
Pharmacological PINK1 activation ameliorates Pathology in Parkinson's Disease models.Res Sq [Preprint]. 2024 May 10:rs.3.rs-4356493. doi: 10.21203/rs.3.rs-4356493/v1. Res Sq. 2024. PMID: 38765977 Free PMC article. Preprint.
-
Bisbiguanide analogs induce mitochondrial stress to inhibit lung cancer cell invasion.iScience. 2024 Mar 27;27(4):109591. doi: 10.1016/j.isci.2024.109591. eCollection 2024 Apr 19. iScience. 2024. PMID: 38632988 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous